View of The Cost of Ignoring Pharmacogenomics: A U.S.Health Economic Analysis of Preventable Statin and Antihypertensive Induced Adverse Drug Reactions

Return to Article Details The Cost of Ignoring Pharmacogenomics: A U.S.Health Economic Analysis of Preventable Statin and Antihypertensive Induced Adverse Drug Reactions Download Download PDF